Patrick Garidel
16Patents
5h-index
33Co-inventors
62Inventor score
Filing activity: May 2, 2005 → Aug 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8096971B2 | Dual chamber container for lyophilization, process for the filling up and use thereof | Human Necessities | 26 | Active |
| US7611709B2 | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives | Human Necessities | 20 | Expired |
| US7723306B2 | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation | Human Necessities | 19 | Active |
| US8002734B2 | Dual chamber container and process for its filling up | Human Necessities | 18 | Active |
| US10513555B2 | Antibody formulations and methods | Chemistry; Metallurgy | 5 | Active |
| US9089529B2 | Antibody formulations and methods | Chemistry; Metallurgy | 3 | Active |
| US8226982B2 | Inhalable powders comprising protein, phenylalanine, and other protein stabilizers | Human Necessities | 3 | Active |
| US9884020B2 | Antibody formulations and methods for treating AL amyloidosis | Chemistry; Metallurgy | 2 | Active |
| US7916289B2 | Apparatus for quantifying shear stress on a formulation comprising biomolecules | Physics | 1 | Active |
| US11078265B2 | Anti-IL-23 antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US9753021B2 | Method for the evaluation of the colloidal stability of liquid biopolymer solutions | Physics | 1 | Active |
| US7727962B2 | Powder comprising new compositions of oligosaccharides and methods for their preparation | Human Necessities | 0 | Active |
| US11352423B2 | Anti-CD19 antibody formulations | Human Necessities | 0 | Active |
| US11897964B2 | Anti-PSGL-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10517830B2 | Antibody formulations and methods | Chemistry; Metallurgy | 0 | Active |
| US11572385B2 | Process for the preparation of concentrated liquid formulations containing biomolecules | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.